{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:30:34Z","timestamp":1792801834450,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.abd.2021.09.008","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:59:52Z","timestamp":1653476392000},"page":"478-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Update on the pathogenesis of vitiligo"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2756-053X","authenticated-orcid":false,"given":"Helena Zenedin","family":"Marchioro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-5765","authenticated-orcid":false,"given":"Caio C\u00e9sar","family":"Silva de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-1713","authenticated-orcid":false,"given":"Vinicius Medeiros","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-8294","authenticated-orcid":false,"given":"Paula Hitomi","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-0002","authenticated-orcid":false,"given":"Gerson","family":"Dellatorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.09.008_bib0005","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2021.09.008_bib0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/pcmr.12681","article-title":"Prevalence of vitiligo in Brazil\u2014a population survey","volume":"31","author":"Castro","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"Castro","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.abd.2021.09.008_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1159\/000448656","article-title":"Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments","volume":"232","author":"Boza","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2021.09.008_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.abd.2020.05.007","article-title":"Consensus on the treatment of vitiligo \u2014 Brazilian Society of Dermatology","volume":"95","author":"Dellatorre","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00439-002-0687-5","article-title":"Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA","volume":"110","author":"Arcos-Burgos","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2003.12.044","article-title":"Characteristics of genetic epidemiology and genetic models for vitiligo","volume":"51","author":"Zhang","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0045","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0050","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.jid.5700953","article-title":"Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population","volume":"127","author":"Jin","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0055","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/sj.jid.5700904","article-title":"Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families","volume":"127","author":"Liang","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2010.337","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP","volume":"131","author":"Birlea","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/jid.2011.240","article-title":"HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo","volume":"132","author":"Singh","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1468-3083.2006.01899.x","article-title":"Association of vitiligo with HLA-A2: a meta-analysis","volume":"21","author":"Liu","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.01.053","article-title":"Fine-mapping analysis of the MHC region for vitiligo based on a new Han-MHC reference panel","volume":"648","author":"Yang","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.abd.2021.09.008_bib0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1073\/pnas.1525001113","article-title":"Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo","volume":"113","author":"Hayashi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.abd.2021.09.008_bib0085","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/430279","article-title":"A novel linkage to generalized vitiligo on 4q13-q21 identified in a genome-wide linkage analysis of Chinese families","volume":"76","author":"Chen","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2","volume":"11","author":"Alkhateeb","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0095","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1086\/375451","article-title":"A genome-wide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci","volume":"72","author":"Fain","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0100","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/ijd.13194","article-title":"Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo: a study of patients with vitiligo from southeast Brazil","volume":"55","author":"Ramire","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0105","article-title":"Meta-analysis of the association between vitiligo and human leukocyte antigen-A","volume":"2016","author":"Li","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.abd.2021.09.008_bib0110","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng.603","article-title":"Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC","volume":"42","author":"Quan","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0120","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.2012.320","article-title":"Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population","volume":"133","author":"Tang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08916930701510848","article-title":"PTPN22: its role in SLE and autoimmunity","volume":"40","author":"Chung","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.abd.2021.09.008_bib0140","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng.952","article-title":"Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease","volume":"43","author":"Rivas","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.abd.2021.09.008_bib0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2019.06.013","article-title":"Family clustering of autoimmune vitiligo results principally from polygenic inheritance of common risk alleles","volume":"105","author":"Roberts","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.abd.2021.09.008_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/abd1806-4841.20142573","article-title":"Vitiligo\u2014part 1","volume":"89","author":"Tarl\u00e9","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0625.2012.01473.x","article-title":"Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin","volume":"21","author":"Ricard","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0165","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jdv.12013","article-title":"Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin","volume":"27","author":"Reichert-Faria","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/exd.12641","article-title":"Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo","volume":"24","author":"Tarl\u00e9","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0175","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbrc.2006.08.138","article-title":"Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo","volume":"349","author":"Schallreuter","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.abd.2021.09.008_bib0180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/exd.12810","article-title":"Genetic and biochemical evidence implicates the butyrylcholinesterase gene BCHE in vitiligo pathogenesis","volume":"24","author":"Nascimento","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-4362.2003.01743.x","article-title":"Value of histopathology in vitiligo","volume":"42","author":"Montes","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/DAD.0b013e3181651511","article-title":"Histopathologic features in vitiligo","volume":"30","author":"Kim","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.abd.2021.09.008_bib0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00403-017-1730-7","article-title":"Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study","volume":"309","author":"Xiong","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jid.2017.09.040","article-title":"Repigmentation of human vitiligo skin by NBUVB is controlled by transcription of GLI1 and activation of the beta-catenin pathway in the hair follicle bulge stem cells","volume":"138","author":"Goldstein","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2340\/0001555576429432","article-title":"Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation","volume":"76","author":"Gniadecka","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0560.1983.tb00328.x","article-title":"Keratinocyte damage in vitiligo","volume":"10","author":"Bhawan","year":"1983","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2021.09.008_bib0215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0220","article-title":"Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo","volume":"5","author":"Boukhedouni","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.abd.2021.09.008_bib0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00403-018-1820-1","article-title":"Effect of Dickkopf1 on the senescence of melanocytes: in vitro study","volume":"310","author":"Rani","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0230","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1111\/ijd.14896","article-title":"Elastin fiber but not collagen fiber is decreased dramatically in the dermis of vitiligo patients","volume":"59","author":"Hirobe","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0235","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/jid.2014.65","article-title":"Melanocytes as instigators and victims of oxidative stress","volume":"134","author":"Denat","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/908797","article-title":"Role of melanin in melanocyte dysregulation of reactive oxygen species","volume":"2013","author":"Jenkins","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.abd.2021.09.008_bib0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/ijdvl.IJDVL_106_17","article-title":"Protective effects of glutamine on human melanocyte oxidative stress model","volume":"84","author":"Jiang","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2021.09.008_bib0250","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.05-4039fje","article-title":"Towards a \u201cfree radical theory of graying\u201d: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage","volume":"20","author":"Arck","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.abd.2021.09.008_bib0255","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1242\/jcs.114.12.2335","article-title":"Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor","volume":"114","author":"Jimenez-Cervantes","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.abd.2021.09.008_bib0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pcmr.12955","article-title":"The fate of melanocyte: mechanisms of cell death in vitiligo","volume":"34","author":"Wu","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0265","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0270","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jdv.14792","article-title":"Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis","volume":"32","author":"Speeckaert","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2310\/7750.2014.14076","article-title":"Low glutathione peroxidase activity levels in patients with vitiligo","volume":"19","author":"Zedan","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.abd.2021.09.008_bib0280","first-page":"701","article-title":"Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo","volume":"38","author":"Akoglu","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2013.11.055","article-title":"The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients","volume":"536","author":"Turkcu","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.abd.2021.09.008_bib0290","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","article-title":"Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy","volume":"42","author":"Karsli","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2018.08.022","article-title":"TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress","volume":"126","author":"Kang","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0300","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/jid.2014.439","article-title":"Suppression of autophagy dysregulates the antioxidant response and causes premature senescence of melanocytes","volume":"135","author":"Zhang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0305","article-title":"Dysregulated autophagy increased melanocyte sensitivity to H2O2-induced oxidative stress in vitiligo","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.abd.2021.09.008_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0315","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0320","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"Boorn","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0330","first-page":"11","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo","volume":"269","author":"Harris","year":"2016","journal-title":"Immunol Ver"},{"key":"10.1016\/j.abd.2021.09.008_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2021.09.008_bib0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.abd.2021.09.008_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate proinflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0350","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0355","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.3390\/molecules23112846","article-title":"Heat shock proteins as immunomodulants","volume":"23","author":"Zininga","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.abd.2021.09.008_bib0360","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bjd.15550","article-title":"Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis","volume":"177","author":"Jacquemin","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0365","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","article-title":"HSP70i is a critical component of the immune response leading to vitiligo","volume":"25","author":"Mosenson","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0370","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0375","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.abd.2021.09.008_bib0380","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.abd.2021.09.008_bib0385","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.12691","article-title":"Inflammasome activation and vitiligo\/nonsegmental vitiligo progression","volume":"170","author":"Marie","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0390","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0395","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","volume":"27","author":"Kroon","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8 + T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2021.09.008_bib0405","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.abd.2021.09.008_bib0410","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0415","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0420","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0425","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0430","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jid.2016.10.048","article-title":"CXCR3 depleting antibodies prevent and reverse vitiligo in mice","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0435","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.abd.2021.09.008_bib0440","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0445","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jid.2019.11.013","article-title":"NKG2D defines a subset of skin effector memory CD8 T cells with proinflammatory functions in vitiligo","volume":"140","author":"Jacquemin","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0450","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","article-title":"Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8(+) T cells activation via JAK-STAT pathway in vitiligo","volume":"139","author":"Chen","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.abd.2021.09.008_bib0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ahmed","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.581433","article-title":"Antigen specificity enhances disease control by Tregs in vitiligo","volume":"11","author":"Mukhatayev","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.09.008_bib0465","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jid.2021.05.022","article-title":"Immunophenotypic analysis reveals differences in circulating immune cells in peripheral blood of segmental and nonsegmental vitiligo patients","volume":"142","author":"Willemsen","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0470","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/ijd.14055","article-title":"Comorbidities in vitiligo: comprehensive review","volume":"57","author":"Dahir","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0475","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.3390\/ijms20225731","article-title":"Melanoma and vitiligo: in good company","volume":"20","author":"Failla","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2021.09.008_bib0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0485","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-pathmechdis-012418-012809","article-title":"Exposure to ultraviolet radiation in the modulation of human diseases","volume":"14","author":"Hart","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.abd.2021.09.008_bib0490","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jid.2009.214","article-title":"Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation","volume":"130","author":"Hariharan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0495","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.15878","article-title":"Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo","volume":"48","author":"Inoue","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2021.09.008_bib0505","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jdermsci.2019.06.009","article-title":"Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma","volume":"95","author":"Arase","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.abd.2021.09.008_bib0510","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2133.1994.tb08486.x","article-title":"Neuropeptide and neuronal marker studies in vitiligo","volume":"131","author":"Al\u2019Abadie","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0515","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13418","article-title":"Psychodermatology of vitiligo: psychological impact and consequences","volume":"33","author":"Simons","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2021.09.008_bib0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1076\/1381345520000710831ZFT262","article-title":"Vitiligo-related neuropeptides in nerve fibers of the skin","volume":"108","author":"Lazarova","year":"2000","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.abd.2021.09.008_bib0525","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1468-3083.2003.00792_6.x","article-title":"Substance P may play a part during depigmentation in vitiligo. A pilot study","volume":"17","author":"Falabella","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.008_bib0530","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2018.7028","article-title":"Association of stress-related disorders with subsequent autoimmune disease","volume":"319","author":"Song","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.abd.2021.09.008_bib0535","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0540","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0749.2004.00149.x","article-title":"Study on the antioxidant status of vitiligo patients of different age groups in Baroda","volume":"17","author":"Agrawal","year":"2004","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.abd.2021.09.008_bib0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46529-6","article-title":"Micro RNAs upregulated in Vitiligo skin play an important role in its aetiopathogenesis by altering TRP1 expression and keratinocyte-melanocytes cross-talk","volume":"9","author":"Vaish","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.abd.2021.09.008_bib0550","article-title":"New insight into the role of exosomes in vitiligo","volume":"19","author":"Wong","year":"2020","journal-title":"Autoimmun Ver"},{"key":"10.1016\/j.abd.2021.09.008_bib0555","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jid.2021.01.036","article-title":"Analysis of matched skin and gut microbiome of patients with vitiligo reveals deep skin dysbiosis: link with mitochondrial and immune changes","volume":"141","author":"Bzioueche","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.09.008_bib0560","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.abd.2020.10.002","article-title":"Decreased circulatory levels of Vitamin D in Vitiligo: a meta-analysis","volume":"96","author":"Varikasuvu","year":"2021","journal-title":"An Bras Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:41:34Z","timestamp":1759794094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0365059622000654"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.008","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the pathogenesis of vitiligo","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}